10 results within Condition Category: Skin and Connective Tissue Diseases Remove filter Countries of recruitment: France Remove filter

• ISRCTN38373718 : Healing efficacy, safety and ease of use of a thin Algostéril

  Overall trial status

  Ongoing

  Recruitment status

  Recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  19/01/2017

• ISRCTN32265704 : Study regarding the safety of Gammanorm in autoimmune diseases

  Overall trial status

  Ongoing

  Recruitment status

  No longer recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  05/07/2016

• ISRCTN84054592 : RITUXILUP - A study to assess if the combination of Rituximab, mycophenolate mofetil (MMF) and no oral steroids is as effective as mycophenolate mofetil and oral steroids in treating lupus nephritis

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  20/01/2014

• ISRCTN62315004 : Clinical efficacy and safety of R0002 cream in the initial and maintenance therapies of lamellar ichthyosis (LI)

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  17/06/2011

• ISRCTN34974208 : Comparison of efficacy and safety of Betesil® medicated plaster versus Daivobet®/Dovobet® ointment in the treatment of chronic plaque psoriasis

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  17/06/2010

• ISRCTN68864186 : Efficacy and safety of Institut Biochimique SA (IBSA) 0.1% betamethasone valerate (BMV) medicated plaster versus reference marketed product for the treatment of chronic plaque psoriasis

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  11/02/2010

• ISRCTN66115464 : Treatment of psoriasis by pulsed dye lasers: short-term and long-term (4 years) results

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  30/09/2008

• ISRCTN19139882 : Long-term efficacy and safety of V0034 CR 01B cream in patients with moderate-to-severe uraemic xerosis

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  04/05/2007

• ISRCTN87782942 : Efficacy and safety of L0133 in the treatment of dermatomyositis and polymyositis: prospective, randomised, double-blind, placebo-controlled study

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  21/12/2006

• ISRCTN49873657 : A double blind, randomised, vehicle-controlled, safety and tolerance study of topical PSK 3841 solution at 5% administered twice daily over four weeks to healthy Caucasian males with androgenetic alopecia

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Skin and Connective Tissue Diseases

  Date assigned

  06/10/2005